Ironwood Pharmaceuticals
In Howard Marks's portfolio · Oaktree Capital Management
Ticker IRWD.CV
Not in the portfolio as of Q2 2026. Every quarter it shows up in a Oaktree Capital Management 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q1 2017 | Reduce 8% | 30,958,000 | 0.6% |
| Q4 2016 | Reduce 23% | 33,658,000 | 0.6% |
| Q3 2016 | Reduce 7% | 43,658,000 | 0.7% |
| Q2 2016 | Buy | 46,958,000 | 0.9% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.